Hims & Hers officer proposes $59.4K share sale

The 2,000 Class A shares were acquired from the issuer through restricted stock vesting on March 15, 2026, as compensation.

Rhea-AI Filing Summary

Hims & Hers Health, Inc. officer Oluyemi Okupe reported a proposed sale of 2,000 Class A shares, with an aggregate market value of $59,400 and an approximate sale date of October 1, 2026. The notice lists prior sales during the preceding three months: 12,313 shares on September 17, 2026, for $354,860.66, and 29,277 shares on September 22, 2026, for $876,846.15.

Key Figures

Proposed sale: 2,000 Class A shares Aggregate market value: $59,400 Prior sale: 12,313 Class A shares +3 more

6 metrics

Proposed sale 2,000 Class A shares Approximate sale date: October 1, 2026

Aggregate market value $59,400 Proposed sale of 2,000 Class A shares

Prior sale 12,313 Class A shares September 17, 2026; aggregate value $354,860.66

Prior sale aggregate value $354,860.66 12,313 Class A shares sold September 17, 2026

Prior sale 29,277 Class A shares September 22, 2026; aggregate value $876,846.15

Prior sale aggregate value $876,846.15 29,277 Class A shares sold September 22, 2026

Key Terms

Rule 144, Restricted Stock Vesting

2 terms

Rule 144 regulatory

"paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Restricted Stock Vesting"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HIMS shares did Oluyemi Okupe plan to sell?

Oluyemi Okupe reported a proposed sale of 2,000 Hims & Hers Health, Inc. Class A shares, with an aggregate market value of $59,400. The approximate sale date is October 1, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/01/2026 - 12:06 PM Accepted by SEC EDGAR 10/01/2026 - 12:05 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001907056
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hims & Hers Health, Inc.
SEC File Number	001-38986
Address of Issuer	2269 CHESTNUT ST #523 SAN FRANCISCO CALIFORNIA 94123
Phone	415-851-0195
Name of Person for Whose Account the Securities are To Be Sold	Okupe Oluyemi
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfieldq RI 02917	2000	59400.00	224935790	10/01/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	03/15/2026	Restricted Stock Vesting	Issuer			2000	03/15/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Oluyemi Okupe 2269 Chestnut Street #523 San Francisco CA 94123	Class A	09/17/2026	12313	354860.66
Oluyemi Okupe 2269 Chestnut Street #523 San Francisco CA 94123	Class A	09/22/2026	29277	876846.15

144: Remarks and Signature

Remarks
Date of Notice	10/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/20/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Oluyemi Okupe
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)